Journal article
Idarucizumab for dabigatran overdose
Abstract
CONTEXT: An overdose of oral anticoagulants represents a challenging scenario for emergency physicians. Dabigatran, an oral direct thrombin inhibitor, is increasingly used in place of warfarin. The lack of an antidote is a concern in patients who overdose on dabigatran, even though the drug can be eliminated with hemodialysis. Idarucizumab is an antibody fragment that binds dabigatran with high affinity. It reverses the anticoagulant effect of …
Authors
Peetermans M; Pollack C; Reilly P; Liesenborghs L; Jacquemin M; Levy JH; Weitz JI; Verhamme P
Journal
Journal of Toxicology Clinical Toxicology, Vol. 54, No. 8, pp. 644–646
Publisher
Taylor & Francis
Publication Date
September 13, 2016
DOI
10.1080/15563650.2016.1187737
ISSN
1556-3650